NewGyn - 1x2ml - Mastelli

NewGyn® is a class III injectable viscoelastic gel, developed by the Italian laboratory Mastelli, a pioneer in polynucleotide research for over 70 years. Designed to treat symptoms related to vulvovaginal atrophy, it combines polynucleotides and hyaluronic acid to regenerate and revitalize intimate tissues. Reserved for qualified physicians, NewGyn® offers a non-surgical clinical approach to sustainably improve the intimate well-being of patients. Mode of action NewGyn® activates fibroblasts, stimulates tissue regeneration, and promotes collagen synthesis. Hyaluronic acid maintains tissue hydration while mannitol protects and prolongs the activity of hyaluronic acid over time. The product acts at three levels simultaneously: Cell regeneration — PN-HPT® polynucleotides stimulate fibroblasts and accelerate tissue renewal Deep hydration — non-crosslinked hyaluronic acid restores the hydration of the mucosa Long-lasting protection — mannitol prolongs the activity of hyaluronic acid and reduces oxidative stress Clinical indications NewGyn® is indicated for women experiencing discomfort related to hormonal changes, childbirth, or aging. It effectively treats: Vaginal dryness Itching and irritations Vulvar pain and dyspareunia Loss of tone and elasticity of the mucosa Vulvovaginal atrophy related to menopause PN-HPT® Technology — The Mastelli Difference Mastelli offers its patented technology of highly purified polynucleotides, known as PN-HPT® (High Purification Technology). The PN-HPT® are natural products derived from fish, obtained through a purification technology that ensures a high level of safety. Mastelli has complete control over its production chain and has conducted over 100 clinical studies, making it one of the most rigorous manufacturers in the polynucleotide market. Composition Component Concentration Polynucleotides PN-HPT® 10 mg/ml Non-crosslinked hyaluronic acid 10 mg/ml Mannitol q.s. Packaging & technical specifications NewGyn® comes in a sterile pre-filled syringe of 2 ml with two 30G ½ needles. Class III medical device. Volume: 2 ml per syringe Needles provided: 2 x 30G ½ Injection depth: intradermal Technique: microdroplet, linear or fan-shaped Classification: Class III medical device — sterile viscoelastic gel Recommended treatment protocol The recommended protocol is one session every 14 to 21 days, for a total of 3 to 4 sessions. Results generally last between 6 and 12 months, depending on the individual patient's profile (skin type, age, hormonal balance). For which patient? NewGyn® is particularly suitable for patients: In the perimenopausal or postmenopausal period Presenting with genitourinary atrophy (GSM syndrome) Having recently given birth with tissue laxity Seeking a non-hormonal alternative to local tritherapy Regulatory information This product is a class III medical device, reserved exclusively for authorized physicians. In accordance with decree no. 2024-490 of May 29, 2024, sales are strictly reserved for healthcare professionals holding a recognized medical degree.